Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1972-9-6
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0008-543X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
22-30
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:4537740-Adenocarcinoma,
pubmed-meshheading:4537740-Adult,
pubmed-meshheading:4537740-Bone Marrow Diseases,
pubmed-meshheading:4537740-Carcinoma, Squamous Cell,
pubmed-meshheading:4537740-Humans,
pubmed-meshheading:4537740-Leucovorin,
pubmed-meshheading:4537740-Lung Neoplasms,
pubmed-meshheading:4537740-Male,
pubmed-meshheading:4537740-Methotrexate
|
pubmed:year |
1972
|
pubmed:articleTitle |
Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer.
|
pubmed:publicationType |
Journal Article
|